by Annie De Groot | Mar 5, 2015 | News, Thinking Out Loud -Blog
Which one is not like the other? Why is one patient more likely to develop a side effect like anti-drug antibodies (ADA) than another? While there are many contributors to immunogenicity, most developers agree that T cell epitopes are key, and because they are, our...